A Study of Tislelizumab in Combination With Chemotherapy Versus Chemotherapy in Advanced Lung Cancer

NCT03594747 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

360

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Small Cell Lung Cancer

Interventions

DRUG: Tislelizumab
DRUG: Paclitaxel
DRUG: Nab-paclitaxel
DRUG: Carboplatin

Sponsor

BeiGene